News

On 16-19 June 2022 close to 100.000 people stopped by Folkemødet – the Danish democracy festival with 2500 debates and events! In a fully packed tent Søren Ziebe sat the scene for an engaging panel discussion on the topic: Involuntary childlessness steals dreams – and labour! Moderator Peter Qvortrup Geisling secured a very engaging debate and involvement from the audience!

Close to 100 delegates participated in the conference with symposia, poster walks and a battle-style debate between Principal Investigators in different disciplines of reproductive medicine. There was plenty of airtime for young researchers as well as excellent networking and the sharing of knowledge and the conference turned out as a great showcase to attract new members to ReproYoung!

Bringing together experts from different disciplines holds a huge potential when it comes to achieving major breakthroughs in science. To drive such interdisciplinary research in male reproduction, the Novo Nordisk Foundation has awarded ReproUnion researcher Kristian Almstrup two major grants.

The study associates assisted reproduction with an increased risk of complications during pregnancy, especially in women aged 35 years or older and those with pre-existing health problems. However, participants in the study were pooled into one group, not distinguishing between different fertility treatments and the techniques used nor between singletons and twin births.

Barbara Sahlin has successfully defended her PhD and a key outcome of the study is the identification of three candidate protein markers of androgen activity, which she hopes can be a tool to better determine testosterone deficiency. Testosterone is crucial for reproductive function.

On the 14th of December 2021 Reproduktionsmedicinsk centrum (RMC) in Malmö opened the doors to their new top-modern facilities. With more operating and consultation rooms up to twice as many fertility patients can be treated and the new facilities also support ReproUnion research activities.

With over 35 years in the reproductive medicine industry, Bernadette brings a wealth of experience to the partnership, said Jens Sønksen when welcoming her to ReproUnion’s Executive Board in the autumn 2021.

The first week of November marks the European Fertility Week – and this year, for the first time ever, it is shedding light on male infertility issues and men’s health. More than 25 million citizens in the European Union are facing fertility issues today with male factor infertility occurring in around 40% of all infertile couples.

The world’s largest male offspring cohort to examine the fetal origin of adult reproductive function (FEPOS) was established as part of Katia Keglberg Hærvig’s PhD project, funded by ReproUnion.

On the 4th of August Nature published the findings from a global collaboration of scientists, who have identified nearly 300 gene variations that influence reproductive lifespan in women. This can lead to potential new targets for fertility treatments as well as ways to improve the prediction of early menopause.